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From June of 2009 to August of 2010 the influenza subtype H1N1pdm09 caused a world-
wide pandemic. The impact on populations and health care systems around the globe
evolved differently. Substantial data come from the German national surveillance network in
an outpatient and private practice setting, while information on hospitalized patients in Ger-
many is rather limited.
Methods
Data from the Federal Statistics Office comprising health insurance claims of the entire
nationwide inpatient sample from 2005 to 2012 were used to identify patients who were hos-
pitalized for laboratory-confirmed influenza and to analyse demographical aspects, comor-
bidities, hospitalization duration, outcomes and ventilator use during the pandemic and
seasonal waves of influenza.
Measurements and main results
A number of 34,493 admissions for laboratory-confirmed influenza occurred during waves
between 2005 and 2012. During the pandemic seasonal waves, the number of hospitaliza-
tions vastly surpassed the level that was seen in any of the seasonal waves. A major demo-
graphic shift was seen with respect to patient age, as younger patients (< 60 years old) were
more frequently hospitalized. Mean length of stay was shorter (149 vs. 193 hours), mean
time on ventilation tended to be shorter (261 vs. 305 hours) in young children (< 4 years old)
and longer (393 vs. 339 hours) in the elderly (> 60 years old). Time to ventilation was shorter
in non-fatal cases (328 vs. 349 hours) and longer in fatal cases (419 vs. 358 hours). Logistic
regression was used to show the impact of comorbidities and co-diagnoses on mortality and
the need for ventilation, as well as differences between pandemic and seasonal influenza.
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Conclusions
Inpatient data suggest differences in patient populations during pandemic and seasonal
influenza. Younger patients were more frequently hospitalized. Differences with respect to
the presence of certain comorbidities and co-diagnoses, length of stay, time to ventilation
and ventilation time could be identified.
Introduction
Influenza is a viral infectious disease that appears as yearly seasonal epidemics of varying sever-
ity[1]. Clinically-relevant morbidity is caused by virus types A and B. Influenza A is further
subtyped according to the haemagglutinin (H) and neuraminidase (N) antigens[1]. Influenza
has major impact on healthcare systems and economies around the globe[1]. Pandemic waves,
i.e., rapid worldwide spreads among large populations, were observed in 1918–1920 (‘Spanish
flu’, A/H1N1), 1957 (‘Asian flu’), 1968 (‘Hong Kong flu’), 1977/78 (‘Russian flu’, A/H1N1)
with the most recent pandemic occurring in 2009 (‘swine flu’, A/H1N1)[2]. Due to the wide
spread of the disease during pandemic waves, a significantly greater morbidity and a higher
death toll can be attributed to influenza pandemics as compared to seasonal occurrences of
influenza[2]. The first cases of the 2009 pandemic were detected in the Mexican federal district
of Mexico City on 18th March, 2009[3–5]. Cases were reported in the southern region of the
United States of America by the end of March[6]. The highest infectious counts of H1N1 in
different countries occurred non-contemporaneously around the globe, with peak numbers in
Germany in November[7].
The available literature on the H1N1 pandemic suggests differences between the pandemic
and seasonal waves of former years with respect to spread, demographics, comorbidities, clini-
cal course and outcomes. Likewise, great international variances could be seen in these param-
eters during the pandemic. In Canada, two distinct waves were reported which differed with
respect to demographics and age distribution, underlying conditions, ICU admissions and
outcomes[8]. Generally, younger patients were affected at a higher frequency during the H1N1
pandemic[3,9–12]. With respect to outcomes, different findings have been reported. In a study
analysing national registry data from France and the United States, younger age could be iden-
tified as a principal risk factor for mortality in these countries, as relative mortality was higher
in younger age groups[13]. Between April and August of 2009, 1,088 lab-confirmed cases were
reported to the California Department of Public Health that resulted in hospitalization or
death. The median age of hospitalized patients was younger than commonly anticipated in sea-
sonal influenza[14]. Infants had the highest hospitalization rates and persons aged 50 years or
older had the highest mortality rates upon hospitalization. Established risk factors for the
potential complications of seasonal influenza were present in most cases. Registry-based sur-
veillance in Denmark revealed that while influenza-associated overall hospitalizations were
not increased as compared to previous seasons, there was a disproportionally large impact on
the age group 5–24 years [9]. Another study from Australia suggested that pregnancy is a risk
factor and is related to more and severe complications (e.g., ICU admission)[15]. A large pop-
ulation-based study of pandemic influenza in the United States identified pregnancy as a risk
factor for hospitalization. A review of 332 fatalities in Argentina revealed comorbidities such
as obesity and pre-existing pulmonary disease as risk factors for a fatal outcome, as well as
pregnancies with a late onset of antiviral treatment[16]. Among 9,966 Chinese patients, the
prevalence of chronic medical conditions, pregnancy, or obesity was significantly higher in
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patients with severe illness than in those with less severe illness [17]. In 112 patients from Mel-
bourne, Australia, pregnancy was a risk factor for hospitalization[18]. This is also implied by
an early American study from April to May 2009 on 34 pregnant women with probable or con-
firmed H1N1 infection[19]. Data obtained by a French institute for public health surveillance
from worldwide sources led to a similar conclusion, that pregnant women and those with met-
abolic comorbidities were at risk for a fatal outcome[20]. A report from New Zealand hinted
that ethnicity played a role, since hospitalizations were markedly higher for Māori and Pacific
peoples compared with Europeans and others[21]. First Nation descent was likewise identified
as a risk factor for severe outcomes (as defined by ICU admission) in a case control study from
Manitoba, Canada[22]. Individual patient data of 542 cases from Manitoba County, USA, also
suggests non-white ethnicity as a risk factor for in-house mortality, as well as chronic lung dis-
ease, a recent history of cancer, immuno-suppression and delay of hospital admission[23]. In-
hospital surveillance data on 205 cases from Ireland showed that age-specific hospitalization
rates were highest in 15- to 19-year-olds and lowest in those aged 65 years and over. Median
length of stay was 24 days. Four hospitalized individuals (2%) died. Asthma, haemoglobinopa-
thies and immunosuppression were the most common comorbidities [24]. An analysis of 440
fatal cases in Great Britain from April 2009 to March 2010 showed that fatal cases were mainly
seen in young adults (median age 43 years) with the highest attributable fractions being
chronic neurological disease (24%), immunosuppression (16%) and respiratory disease (15%)
[25]. In a multivariate analysis, risk factors for disease severity among patients hospitalized
for H1N1 in Spain from April to December 2009 were identified as starting antiviral therapy
more than 48 hours after symptom onset, morbid obesity, cardiovascular disease and chronic
obstructive pulmonary disease[26].
To date, German inpatient data have not been made available at a larger scale. Multicentre
data from 15 participating hospitals were aggregated within the pandemic influenza surveil-
lance network (PIKS), but the observation period only spanned the 49th week of 2009 to the
12th week of 2010, unfortunately well beyond the peak influenza wave, so that the majority of
hospitalizations were actually missed[27]. In addition, inpatient data were only partially col-
lected, from reports which are made available by the Robert Koch Institute and which rely on
the legal requirement to report influenza cases to the departments of health (Infektionsschutz-
gesetz)[7,28]. Data tend to be incomplete with regard to comorbidities and are not available
before the 29th week of 2009[7]. No detailed data on key variables, such as the use of ventilation
or length of stay are thus available. This applies even more to seasonal influenza epidemics in
former years. We hereby aim to present the data of all hospital admissions in Germany aggre-
gated from nationwide insurance claims.
Material and methods
Database
International Classification of Diseases, version 10 (ICD-10) data coded according to G-DRG
(German modification of the diagnosis related groups) were obtained from the Federal Statisti-
cal Office of Germany (DeStatis). DeStatis holds data on nationwide health insurance claims of
the entire inpatient sample. Since there is a legal requirement for healthcare insurance which
applies to the vast majority of the German population, the inpatient sample is nearly fully
assessed. Data sets comprise detailed pseudonymized information on age, gender, admission
and dismissal times, primary diagnoses and 89 co-diagnoses, as well as 100 operation and pro-
cedure keys (OPS). OPSs are codes that reflect the German modification of the international
classification of procedures in medicine (ICPM), which allow access to information such as
time of intubation and hours of mechanical ventilation. Data were aggregated and analysed
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using SAS 9.4. Where aggregated query data resulted in numbers less than three, data were
censored in compliance with the DeStatis anonymization policy.
Case selection
Patient data sets were selected by screening for influenza-related ICD-Codes, including J09 for
pandemic influenza (i.e., influenza due to certain identified influenza viruses including the
influenza A/H1N1 pandemic of 2009 known as swine flu) and J10 (i.e., influenza due to
another identified influenza virus). Additionally, data sets containing the code U69.20 (a spe-
cial code for H1N1 influenza) were selected. Where specified, the code J11 (i.e., influenza as a
clinical diagnosis although the virus was not identified) was included. J09 and J10 encode labo-
ratory-confirmed influenza. J11 relies upon a clinical diagnosis and therefore largely corre-
sponds to the term ‘influenza-like illness’ (ILI) but does not allow a definite diagnosis. Cases
were selected from the time frame of the German influenza wave, largely based on the defini-
tion of the German influenza surveillance service (Robert-Koch Institut).
Statistical analysis
Demographics and descriptive statistics were derived from the above-mentioned data sets to
characterize patients with regard to gender, age, comorbidities and co-diagnoses, length of stay,
time from admission to intubation and hours of mechanical ventilation. Diagnosis codes are
given in S4 Table. Differences between the H1N1 2009 pandemic influenza and seasonally
occurring epidemic influenza were highlighted. To further explore differences between pan-
demic and seasonal influenza concerning underlying comorbidities and co-diagnoses, logistic
regression was performed with the presence of pandemic influenza in one patient as the out-
come variable. To examine the impact of comorbidities and co-diagnoses on endpoints, such as
mortality and the need for mechanical ventilation, several explorative analyses were performed
using logistic regression. Length of stay, hours until intubation and hours of mechanical ventila-
tion were compared using the Kruskal-Wallis test followed by the Wilcoxon test. Categorical
variables were compared using the chi-squared test. Hospitalizations, use of mechanical ventila-
tion and mortality rates were compared between pandemic and seasonal influenza and odds
ratios were calculated. The hospitalization rate per 100,000 individuals per season was calcu-
lated using the age- and gender-specific census from 2011, as provided by DeStatis.
Results
Overall hospitalizations
Fig 1 shows a graphic representation of influenza waves from 2004/05 until 2011/12. Numbers
represent patients hospitalized according to J09/J10 ICD codes (confirmed influenza cases).
Marked differences between the seasons from 2004/05 until 2008/09 and the 2009/2010 pan-
demic can be seen with respect to the overall numbers of hospitalizations and the timing of the
main influenza wave. While the highest numbers of hospitalizations due to seasonal influenza
waves in Germany are usually to be anticipated between January and March, the 2009 pan-
demic wave reached its peak markedly earlier, in October and November of 2009. The ICD sta-
tistics also suggest a much higher number of influenza-related hospitalizations for pandemic
influenza as compared to previous seasonal outbreaks.
Age and gender distribution of hospitalized cases
As outlined in the introduction, studies from other countries and previous reports from Ger-
many’s legal reporting system for influenza cases indicate that an unanticipatedly high
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caseload of influenza was seen in patients younger than 60 years old with pandemic influenza
as compared to seasonal influenza. Table 1 shows the distribution of cases among patients
hospitalized for seasonal and 2009/10 pandemic influenza in Germany. Hospitalization rates
among all age groups are higher during the pandemic. Yet the age-specific hospitalization
rates of patient groups younger than 60 years old are higher than in seasonal influenza; accord-
ingly, patients older than 60 are less frequently hospitalized, even after consideration of the
higher overall hospitalization rate. Unadjusted odds suggest that very young patients (0–4
years old) and older patients (> 60 years old) are comparably less frequently hospitalized
(Table 1). Logistic regression confirms this view (Figs 2–4, see below). The odds of hospitaliza-
tion show a slight preference for the female sex in pandemic influenza. Logistic regression sug-
gests that after adjustment for other factors, such as comorbidities, neither the male nor female
sex is preferably hospitalized in pandemic influenza as opposed to seasonal influenza (Fig 2A).
Age and gender distribution among cases of mechanical ventilation
As shown in Table 1, gender-specific proportions among ventilated patients show a preference
for the male sex in pandemic influenza (proportions of 41.9 vs. 36.8%). Likewise, younger
patient groups < 60 years old, and most prominently those between 15–35 and 35–59 years
old require mechanical ventilation (MV) more frequently during pandemic influenza rather
than seasonal influenza. Yet, with respect to hospitalized patients, the age- and gender-specific
rates of mechanical ventilation show that in fact older patients (> 60 years old) have higher
odds of MV in pandemic influenza. Younger age groups either do not show differences in MV
rates or have lower MV rates (particularly those between 35 and 59 years old). Female patients
have significantly lower odds of MV in pandemic influenza. Higher frequencies or proportions
of MV are thus most likely explained by the higher hospitalization rates of specific subgroups.
The overall rate of mechanical ventilation in patients does not appear to be higher in pandemic
influenza (4.48%) as compared to seasonal influenza (4.95%), and the OR of pandemic influ-
enza vs. seasonal influenza is 0.9. This is confirmed by logistic regression upon age adjustment
(Fig 2C).
Gender- and age-specific mortality among hospitalized cases
A similar distribution in age and gender proportions, as seen in hospitalizations and use of
MV, can be observed in the in-hospital mortality rate of influenza cases (Table 1). Age- and
gender-specific mortality is not higher in younger patients in pandemic influenza than would
Fig 1. Graphical illustration of the total number of hospitalized cases. Seasonal influenza waves and the
H1N1 pdm09 wave, according to the ICD statistics of the German Federal Statistical Office. Cases comprise
the ICD codes J09 and J10 representing laboratory-confirmed cases.
https://doi.org/10.1371/journal.pone.0180920.g001
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Table 1. Hospitalizations, mechanical ventilation and fatal cases in seasonal influenza waves and the 2009 pandemic.
Hospitalizations
Seasonal Flu Pandemic Flu Pandemic vs. Seasonal
Gender N (% All) Hospitalization Rate N (% All) Hospitalization Rate unadj. OR (CI) p-value
Female 9,704 (46.6) 3.38 6,554 (47.9) 15.96 1.05 (1.01–1.1) 0.0235
Male 11,102 (53.4) 4.05 7,133 (52.1) 18.22 0.95 (0.91–0.99)
Age Group
0–4 6,328 (30.4) 27.07 2,989 (21.8) 89.52 0.64 (0.61–0.67) < 0.0001
5–14 4,623 (22.2) 8.85 3,566 (26.1) 47.76 1.23 (1.17–1.3) < 0.0001
15–34 3,078 (14.8) 2.38 3,500 (25.6) 18.95 1.98 (1.87–2.09) < 0.0001
35–59 3,614 (17.4) 1.74 2,711 (19.8) 9.12 1.17 (1.11–1.24) < 0.0001
> 60 3,163 (15.2) 2.13 921 (6.7) 4.34 0.40 (0.37–0.43) < 0.0001
All 20,806 (100) 3.71 13,687 (100) 17.06
Mechanical Ventilation
N (% All)
Seasonal Flu Pandemic Flu Pandemic vs. Seasonal
Gender N (% All) MV Rate (%) N (% All) MV Rate (%) unadj. OR (CI) p-value
Female 651 (63.2) 6.71 356 (58.1) 5.43 0.8 (0.7–0.91) 0.0009
Male 379 (36.8) 3.41 257 (41.9) 3.6 1.06 (0.89–1.25) 0.4968
Age Group
0–4 100 (9.7) 1.58 39 (6.4) 1.3 0.82 (0.57–1.2) 0.3059
5–14 39 (3.8) 0.84 31 (5.1) 0.87 1.03 (0.64–1.66) 0.9003
15–34 118 (11.5) 3.83 125 (20.4) 3.57 0.93 (0.72–1.2) 0.5737
35–59 463 (45) 12.81 302 (49.3) 11.14 0.85 (0.73–0.99) 0.0436
> 60 310 (30.1) 9.8 116 (18.9) 12.6 1.33 (1.06–1.66) 0.0146
All 1,030 (100) 4.95 613 (100) 4.48 0.9 (0.81–1) 0.0441
Fatal Cases
N (% All)
Seasonal Flu Pandemic Flu Pandemic vs. Seasonal
Gender N (% All) Fatality Rate (%) N (% All) Fatality Rate (%) unadj. OR (CI) p-value
Female 362 (62.5) 3.73 168 (57.3) 2.56 0.68 (0.56–0.82) <0.0001
Male 217 (37.5) 1.95 125 (42.7) 1.75 0.89 (0.72–1.12) 0.326
Age Group
0–4 26 (4.5) 0.41 9 (3.1) 0.3 0.73 (0.34–1.56) 0.4188
5–14 24 (4.1) 0.52 18 (6.1) 0.5 0.97 (0.53–1.79) 0.928
15–34 48 (8.3) 1.56 37 (12.6) 1.06 0.67 (0.44–1.04) 0.0719
35–59 219 (37.8) 6.06 145 (49.5) 5.35 0.88 (0.71–1.09) 0.2294
> 60 262 (45.3) 8.28 84 (28.7) 9.12 1.11 (0.86–1.44) 0.422
All 579 (100) 2.78 293 (100) 2.14 0.76 (0.66–0.88) 0.0002
The upper panel shows total hospitalizations (N) for different age groups and both sexes. Age and gender proportions are given in parentheses (% of all).
The hospitalization rate is given as cases per 100,000 persons per season, of each respective subpopulation. The unadjusted odds (OR) of hospitalization
are given to compare seasonal and pandemic influenza. P-values and 95% confidence intervals are given. The middle panel shows the absolute number of
patients requiring mechanical ventilation (MV). The age- and gender-specific proportions are given in parentheses (% of all). The age- and gender-specific
rates of mechanical ventilation (MV rate) were calculated in relation to the respective group of all hospitalizations. The given odds ratios compare age- and
gender-specific MV rates. P-values and 95% confidence intervals are given. The lower panel shows the absolute number of fatal cases for different age
groups and both sexes (N). Age- and gender-specific proportions among fatal cases are given in parentheses (% of all). The age- and gender-specific
fatality rate is given. The given odds ratios are to compare age- and gender-specific fatality rates. P-values and 95% confidence intervals are given.
https://doi.org/10.1371/journal.pone.0180920.t001
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be anticipated from the data on seasonal influenza waves. Overall in-hospital mortality is
rather lower in pandemic influenza. Logistic regression confirms that age-adjusted overall
mortality remains at the same levels as seen in seasonal influenza (Fig 2B).
Time until usage of ventilation
The mean time from hospital admission until the start of ventilation is not significantly differ-
ent between seasonal and pandemic influenza except for the group of older patients. However,
there is a trend towards earlier intubation (140 vs. 174 hours, Table 2). This difference is more
pronounced in fatal cases (Table 2, S2 Table) and varies among age groups.
Time of mechanical ventilation
Overall, mean time (in hours) of mechanical ventilation per case do not differ in pandemic
and in seasonal influenza (Table 2), though ventilation times are generally longer in fatal cases
and shorter in non-fatal cases, depending on the selected age group (see S3 Table).
Fig 2. Odds ratios of pandemic vs. seasonal influenza. Logistic regression was used to estimate the difference of pandemic and
seasonal influenza regarding age, gender, death, mechanical ventilation, and certain co-diagnoses. Presence of pandemic influenza was
set as the outcome variable. ORs of greater than 1 meaning the analysed factor occurring favourably in pandemic influenza cases. (A) ORs
for pre-existing comorbidities, age and gender, (B) OR for co-diagnoses and complications. (C) ORs for mechanical ventilation and age, (D)
ORs for death and age. ORs and their respective 95% confidence intervals are determined by logistic regression. Pandemic influenza was
set as the outcome, therefore ORs greater than 1 favour pandemic over seasonal influenza.
https://doi.org/10.1371/journal.pone.0180920.g002
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Length of stay
The average length of stay per case is shorter in pandemic influenza than in seasonal influenza
(Table 2). This trend is more pronounced in non-fatal cases with more similarity in fatal cases,
except for very young patients (0–4 years old) (see S1 Table).
Comorbidities and complications of hospitalized cases
Comorbidities and complications impacting mechanical ventilation and fatal out-
comes. As depicted in Fig 3A–3D, logistic regression suggests that comorbid conditions
including tachyarrhythmia, immunosuppression, chronic obstructive pulmonary disease,
chronic heart failure, chronic anaemia, body weight disorders (especially obesity), male sex
and older age are risk factors either for fatal outcomes (Fig 3A and 3B), mechanical ventilation
(Fig 3C and 3D) or both in pandemic and seasonal influenza. Diabetes may be another risk
Fig 3. Influence of comorbidities and long-standing diagnoses on the outcome of mechanical ventilation and death in seasonal
and pandemic influenza. Logistic regression was used to estimate the influence of certain variables, such as age, gender and
comorbidities on outcomes of mechanical ventilation and death. (A) Influence of comorbidities on fatal outcomes in seasonal influenza.
ORs greater than 1 mean that the analysed factor occurred favourably in fatal cases. (B) Influence of comorbidities on fatal outcomes in
pandemic influenza. ORs greater than 1 mean that the analysed factor occurred favourably in fatal cases. (C) Influence of comorbidities on
the outcome of MV in seasonal influenza. ORs greater than 1 mean that the analysed factor occurred favourably in MV cases. (D) Influence
of comorbidities on the outcome of MV in pandemic influenza. ORs greater than 1 mean that the analysed factor occurred favourably in MV
cases.
https://doi.org/10.1371/journal.pone.0180920.g003
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factor for both outcomes in pandemic influenza (Fig 3B and 3D). Younger age is generally pro-
tective with regard to these outcomes in seasonal and pandemic influenza.
Fig 4A–4D shows the impact of co-diagnoses and complications on fatal outcomes (Fig 4A
and 4B) and mechanical ventilation (Fig 4C and 4D) as estimated by logistic regression. Adult
respiratory distress syndrome (ARDS), acute renal injury, acute anaemia, thrombocytopenia,
SIRS or Sepsis, respiratory failure, agranulocytosis and acidosis seem to be associated with fatal
outcomes in seasonal and pandemic influenza. Hospital-acquired pneumonia alone does not
appear to be an independent predictor of mortality (Fig 4A and 4B) in this model but seems to
be associated with mechanical ventilation (Fig 4C and 4D), while thrombocytopenia is not sig-
nificantly associated with mechanical ventilation. The other complications tend to have similar
relevance to mechanical ventilation as to mortality, given individual differences in effect sizes.
Fungal pneumonia is a significant complication for both outcomes in seasonal influenza (Fig
4A and 4C) but not in pandemic influenza (Fig 4B and 4D).
Fig 4. Influence of co-diagnoses and complications on the outcome of mechanical ventilation and death in seasonal and
pandemic influenza. Logistic regression was used to estimate the influence of certain variables, such as age, gender and co-diagnoses on
outcomes of mechanical ventilation and death. (A) Influence of co-diagnoses on fatal outcomes in seasonal influenza. ORs greater than 1
mean that the analysed factor occurred favourably in fatal cases. (B) Influence of co-diagnoses on fatal outcomes in pandemic influenza.
ORs greater than 1 mean that the analysed factor occurred favourably in fatal cases. (C) Influence of co-diagnoses on the outcome of MV in
seasonal influenza. ORs greater than 1 mean that the analysed factor occurred favourably in MV cases. (D) Influence of co-diagnoses on
the outcome of MV in pandemic influenza. ORs greater than 1 mean that the analysed factor occurred favourably in MV cases.
https://doi.org/10.1371/journal.pone.0180920.g004
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Differences concerning comorbidities and co-diagnoses. Fig 5 shows the percentages of
comorbidities and co-diagnoses in seasonal and pandemic influenza. Subgroups of patients
receiving MV (Fig 6) and fatal cases (Fig 7) are analysed separately. Looking at the entire sam-
ples of hospitalized patients, only a minor part of comorbidities and co-diagnoses are relatively
more frequent in the pandemic cases, e.g., pneumonia, pregnancy, ARDS and asthma (but not
COPD) (Fig 5). Many comorbidities that are typically related to advanced age are relatively
more frequent in seasonal influenza (e.g., cardiac, vascular, cerebral, or metabolic disease).
ARDS, pneumonia, pregnancy and asthma seem to be more frequent among ventilated
patients with pandemic influenza (Fig 6). Co-diagnoses indicating a severe course of disease
(e.g., ARDS, SIRS or Sepsis, fungal pneumonia) are more frequent among fatal cases of pan-
demic influenza (Fig 7). For further reference, S5 Table contains all underlying data regarding
absolute and relative frequencies of comorbidities. Fig 2A summarizes the results of logistic
regression analyses, which investigated whether certain comorbidities are associated with the
2009 pandemic influenza rather than the seasonal influenza. Thus, age-adjusted odds ratios
greater than 1 favour pandemic influenza over seasonal influenza. Interestingly, respiratory
comorbidities such as asthma and COPD seem to be risk factors for pandemic influenza in
this model. Pregnancy also seems to be associated with pandemic influenza cases. Chronic
heart failure, immunosuppression and low body weight (but not adipositas), on the other
hand, are associated with seasonal influenza. Other comorbidities, including renal disease,
tachyarrhythmia, coronary artery disease, GERD, diabetes and chronic anaemia do not seem
to occur more frequently in either type of influenza. There is also no preference for any sex.
Younger age groups have a higher likelihood to be among pandemic influenza cases. Fig 2B
points at co-diagnoses that could be associated with pandemic rather than seasonal influenza,
as calculated by logistic regression. Odds ratios greater than 1 are in favour of the 2009 pan-
demic influenza. Respiratory co-diagnoses, such as pneumonia, fungal pneumonia and adult
respiratory distress syndrome are more likely to be associated with pandemic influenza cases.
Exceptions to these are hospital-acquired pneumonias and acute respiratory failure. Complica-
tions like otitis media or gastroenteritis are more frequently seen in seasonal influenza cases.
Table 2. Length of stay, time until intubation and hours of ventilation.
Length of Stay Time until Intubation Hours of Ventilation
Gender Seasonal Flu Pandemic Flu p-value Seasonal Flu Pandemic Flu p-value Seasonal Flu Pandemic Flu p-value
Female 185/114 (± 262) 146/87 (± 219) <.0001 176/43 (± 380) 126/44 (± 214) 0.9225 342/216 (± 446) 335/202 (± 371) 0.7709
Male 199/111 (± 329) 153/82 (± 264) <.0001 173/45 (± 371) 151/31 (± 439) 0.3126 363/233 (± 442) 364/217 (± 481) 0.3239
Age Group
0–4 140/97 (± 246) 118/83 (± 171) <.0001 316/63 (± 734) 173/85 (± 267) 0.8326 305/183 (± 419) 261/196 (± 211) 0.3064
5–14 115/75 (± 184) 94/67 (± 122) <.0001 113/17 (± 285) 157/74 (± 219) 0.0614 256/129 (± 309) 264/160 (± 364) 0.5976
15–34 158/93 (± 263) 122/72 (± 200) <.0001 150/35 (± 283) 108/21 (± 232) 0.1529 353/192 (± 374) 328/215 (± 359) 0.4178
35–59 288/150 (± 421) 232/126 (± 361) <.0001 140/32 (± 284) 147/44 (± 455) 0.1995 384/260 (± 514) 368/229 (± 489) 0.1721
> 60 339/240 (± 323) 325/207 (± 351) <.0001 198/70 (± 352) 142/48 (± 246) 0.0381 339/223 (± 363) 393/209 (± 439) 0.8203
Fatal Cases 513/348 (± 626) 484/331 (± 503) <.0001 235/70 (± 417) 177/57 (± 300) 0.1982 368/245 (± 506) 419/289 (± 452) 0.2070
Non-Fatal Cases 184/111 (± 280) 142/83 (± 229) <.0001 147/35 (± 350) 127/34 (± 382) 0.9857 349/221 (± 416) 328/196 (± 430) 0.0882
All 193/113 (±300) 149/85 (±243) <.0001 174/44 (± 374) 140/37 (± 362) 0.3736 355/227 (± 444) 352/212 (± 438) 0.3182
The left section of the table compares the age- and gender-specific length of hospital stay between pandemic and seasonal influenza. The middle section of
the table compares the time until intubation. The right part of the table compares hours of ventilation. Data are given in mean/median hours ± standard
deviation. Numbers were rounded to full hours. The Wilcoxon test was used to compare age- and gender-specific length of stay, time until intubation and
hours of ventilation.
https://doi.org/10.1371/journal.pone.0180920.t002
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Fig 5. Relative frequencies of comorbidities and co-diagnoses in pandemic and seasonal influenza.
Relative frequencies are given as a percentage of all hospitalized patients. Comorbidities are ordered by the
magnitude of the absolute difference in relative frequencies between pandemic (red) and seasonal influenza
(blue). Comorbidities that number less than three are censored in compliance with the DeStatis data
protection policy.
https://doi.org/10.1371/journal.pone.0180920.g005
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Fig 6. Relative frequencies of comorbidities and co-diagnoses in patients receiving mv in pandemic
and seasonal influenza. Relative frequencies are given as a percentage of all hospitalized patients receiving
MV. Comorbidities are ordered by the magnitude of the absolute difference in relative frequencies between
pandemic (red) and seasonal influenza (blue). Comorbidities that number less than three are censored in
compliance with the DeStatis data protection policy.
https://doi.org/10.1371/journal.pone.0180920.g006
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Fig 7. Relative frequencies of comorbidities and co-diagnoses in fatal cases of pandemic and
seasonal influenza. Relative frequencies are given as a percentage of all fatal cases. Comorbidities are
ordered by the magnitude of the absolute difference in relative frequencies between pandemic (red) and
seasonal influenza (blue). Comorbidities that number less than three are censored in compliance with the
DeStatis data protection policy.
https://doi.org/10.1371/journal.pone.0180920.g007
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This is also true for acute renal failure and thrombocytopenia, while acute anaemia and agran-
ulocytosis and sepsis do not favour pandemic or seasonal influenza. Logistic regression sug-
gests that bacterial germs, probably in part associated with HAP (pseudomonas, S. aureus)
and/or antibiotic treatment (C. difficile) are more frequently associated with seasonal influenza
cases (S5 Table). After all, differences between pandemic and seasonal influenza are seen with
respect to unadjusted relative frequencies of comorbidities and co-diagnoses, and differences
are still suggested after adjustment by logistic regression.
Discussion and conclusion
The G-DRG data suggest that the 2009/10 pandemic influenza has distinct characteristics
when compared to seasonal influenza waves. The study allows for the identification of comor-
bidities and co-diagnoses that are more frequently associated either with pandemic or seasonal
influenza, and can identify their impact on outcomes such as in-hospital mortality and the
need for mechanical ventilation. Based upon statutory reports, Buda et al. reported a number
of n = 7,882 influenza hospitalizations from the 18th week of 2009 until the 17th week of 2010.
This is a considerably lower count than estimated from the G-DRG database (Fig 1, Table 1).
Obvious differences with respect to the data sources can be explained by the legal requirement
to report an influenza case (or suspicion of one) and the G-DRG coding of cases for the pur-
pose of health insurance claims. In general, the number of reported cases is considered an
underestimation of the actual count, and strongly depends on the legal and medical infrastruc-
ture of the reporting country. The G-DRG database represents a retrospective cohort and data
monitoring is not performed as in prospective cohorts. Nonetheless, data quality is ensured
since diagnosis and coding quality is monitored by the professional medical service to the
statutory health insurance, which reviews roughly 10% of all insurance claims[29]. Thus, the
G-DRG data indicate that the burden of influenza-related hospitalization in Germany may be
higher than estimated by the data from the statutory reporting system alone.
A considerable age shift in individuals affected by different types of influenza has been pre-
viously reported and can be confirmed using the G-DRG data[28]. Younger patients were
more frequently hospitalized during the 2009/10 influenza pandemic, with only very young
patients (0–4 years old) as an exception to this[14]. Younger patients were more frequently
mechanically ventilated and more often had a fatal outcome in pandemic influenza in total,
but not in relation to the hospitalized population. This is in accordance with previously pub-
lished data[13]. Yet age- and gender-specific MV rates were not elevated in young patients and
were in fact higher in older patients aged 60 and over. Overall, mortality rates and rates of
mechanical ventilation were not elevated when pandemic influenza is compared to seasonal
influenza in this cohort of hospitalized patients. Yet when fatal and non-fatal cases are com-
pared separately, a longer duration of mechanical ventilation and a shorter time until intuba-
tion, especially in younger patients, are observed in fatal cases of pandemic influenza, although
this is not statistically significant. Pre-existing respiratory diagnoses, including COPD and
asthma, and co-diagnoses such as ARDS or pneumonia may be associated with pandemic
influenza. Taken together, the data support previously-reported findings that pandemic influ-
enza may have a more severe course of disease in a subset of patients[14,18,20,28,30]. The
length of stay was found to be shorter in pandemic influenza. This was consistently seen in
fatal and non-fatal cases and across age groups and genders. One explanation may be an earlier
and broader administration of anti-viral treatment due to increased awareness towards influ-
enza, especially in 2009. On the other hand, increased demand of hospital resources might
have led to an increased patient turn-over and reduced overall length of stay. Pregnancy has
been previously reported to be an important risk factor for the 2009 pandemic influenza.
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Explorative analyses of the G-DRG data hint in this direction. As reported by others, preg-
nancy seems to be rather associated with pandemic influenza than with seasonal influenza[31].
Logistic regression does not indicate that it increases the odds of worse outcomes such as
mechanical ventilation or death, although some reports point towards complications in preg-
nant patients[15,18–20,32,33].
This study describes differences between seasonally circulating and pandemic influenza
(H1N1). However, after the 2009 pandemic, H1N1 appeared also as a seasonal strain. It is
believed that when the novel form of H1N1 arose in 2009, it encountered a global population
with only limited immunity (older patients) or no immunity (younger patients)[3,12,30,34]. It
thus caused a pandemic spread and displayed the distinguishing features detailed here and in
previous studies. Older patients may have experienced contact with H1N1 previously, while
young patients had not. Since then, the pandemic 2009 H1N1 strain has continued circulating.
This study cannot distinguish pathogen- or strain-specific aspects that that affect hospitaliza-
tion hospitalization from other epidemiological factors (i.e., the environment, climate or
travel).
Limitations to this study arise from the fact that the data regarding all diagnoses and proce-
dures were primarily collected in order to facilitate the processing of insurance claims. Bias
might have therefore been introduced with respect to the selection of certain diagnoses or co-
diagnoses. Confidence, on the other hand, comes from the fact that important findings from
this study accord with the reports by investigators from other countries.
Taken together, these results represent a source of information for the preparation against
future waves of influenza. Populations that are typically less affected by seasonal influenza,
such as younger patients, should particularly be the focus of preventive measures. However,
the well-established respiratory comorbidities, such as asthma and COPD, also show a stron-
ger association with pandemic than seasonal influenza. Vaccination strategies should particu-
larly target these risk groups. To our knowledge, this is the first study to evaluate large-scale
German in-hospital data and is therefore a valuable supplement to the previously published
sentinel network data and statutory reporting system data.
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as well as fatal and non-fatal cases. The chi-squared test was used to compare differences
between seasonal and pandemic influenza (all patients) and the according p-values are stated.
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